Dr. Giovanni Giaroli is a Child and Adolescent Consultant Psychiatrist but also trained and qualified in General Adult Psychiatry.
He is an Honorary Clinical Senior Lecturer of Psychopharmacology and also a Cognitive Analytic Therapy practitioner.
Dr. Giaroli works as a visiting consultant for both the inpatient and outpatient units at The Priory Hospital in North London.
He is also work as a substantive consultant in Child and Adolescent Psychiatry at North East London Foundation Trust (NHS).
As a result of his passion for education and teaching, he regularly lectures to medical students for the Brain & Behaviour and Medicine & Society modules at St Mary University of London. He is the leader of the Module of Psychopharmacology for the Master in Mental Health Studies at the Institute of Psychiatry, King's College, London.
Full diagnosis and ongoing treatment (children and adolescents) of:
- ADHD (including adults)
- ASD (Autism Spectrum Disorder- using ADOS and 3Di) (including adults)
- Tourette Syndrome and Tic Disorders
- Conduct Disorder and Oppositional Disorder
- Bipolar Disorder and Unipolar Depression
- Post-Traumatic Stress Disorder
- Sleeping disorders
- Cognitive Analytic Therapy (Psychotherapy)
- Consultations and second opinions on all psychopharmacological matters for children, adolescents and adults.
Consultant Child and Adolescent Psychiatrist at the North East London Foundation Trust
Honorary Lecturer and Module Leader of Pharmacotherapy for the Master in Mental Health at The Institute of Psychiatry, King's College, London.
Honorary Senior Lecturer for Barts & St Mary Medical School, London
- Graduated (with top honours) in Medical School at the University of Modena and Reggio Emilia, Italy, 2001 (MD).
- Specialised (with top honours) in General Adult Psychiatry at the World Health Organisation (WHO) Collaborating Centre of Verona, Italy, 2005.
- Specialized in Child & Adolescent Psychiatry at the Royal Children’s Hospital in Melbourne, Australia, 2007.
- Diploma in Cognitive Analytic Therapy at St Thomas’ Hospital, London, 2011
“I strongly believe that innovation and research must be brought into the clinical practice in order to offer the patients the most up-to-date and evidence based service possible”.
Dr. Giaroli is actively involved in research for medication for psychiatric conditions and the genetic aspects of several psychiatric syndromes.
He has published in multiple International Journals on Psychopharmacology (see below) and is a regular chair and presenter at international conferences (United States, Australia, Denmark, Ireland, Turkey and Portugal).
J R Barrett, D K Tracy, G Giaroli (2013): To sleep or not to sleep: a systematic review of literature of pharmacological treatments of insomnia in Attention-Deficit Hyperactivity Disorder children and adolescents. Journal of child and adolescent psychopharmacology Dec (10) 640-7
J. Memarzia, DK Tracy, G Giaroli : (in press on Journal of Psychopharmacology)“ Antipsychotics in pre-schoolers: a veto or a sensible option?”
S. Molteni, G. Giaroli R. Comelli, U. Balottin (2014): Subjective Experience in a cohort of adolescents treated with antipsychotics. J Clin Psychopharmacol. 2014 Feb;34(1):99-108.
K V Sendt, G Giaroli, DK Tracy (2012):” Beyond dopamine: glutamate as a target for future antipsychotics” International Scholarly Research Network ISRN Pharmacology Volume 2012, Article ID 427267, 9 pages doi:10.5402/2012/427267
L.Loyd, G. Giaroli, D. Taylor and D. Tracy (2011) "Bipolar Depression: Clinically missed, pharmacologically mismanaged. Therapeutic Advances in Psychopharmacology 0(0) 1:10.
Matteo Balestrieri, Giovanni Giaroli, Mariangela Mazzi, Cesario Bellantuono (2006) "Performance of the Italian version of Subjective Well Being Under Neuroleptic (SWN) Scale in Schizophrenic Outpatients." Pharmacopsychiatry May 39(3) 81-84.
Gian Maria Galeazzi, Silvia Ferrari, Giovanni Giaroli, Andrew Mackinnon, Elisa Merelli, Luisa Motti, Marco Rigatelli (2005) "Psychiatric Disorders, Depression, Disability, and Interferon Beta Therapy in Multiple Sclerosis Outpatients" Neurological Sciences 26(4):255-62.